ICUI ICU MEDICAL INC/DEcompanySEC Filings & Insider Trading Activity 2026
Latest ICU MEDICAL INC/DE (ICUI) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 19, 2026, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on February 20, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for ICU MEDICAL INC/DE (ICUI) (SEC CIK 883984), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business model: Development, manufacturing, and sales of innovative medical products for infusion therapy, vascular access, and vital care applications worldwide
- • New strategic joint venture formed in April 2025, selling 60% controlling interest in IV Solutions business to Otsuka Pharmaceutical Factory America
Risk Factors
- • Regulatory risk Italy Medical Device Payback law IMDP liability settled for $2.5M with $3.8M reserve release in 2025
- • Macroeconomic exposure $85M-$100M capital expenditures planned across Costa Rica, Europe, Mexico, and U.S. manufacturing in 2026
Management Discussion & Analysis
- • Foreign currency exposure partially hedged, not fully covering forecasted revenues and expenses
- • Potential increased risk from unhedged currency fluctuations impacting financial results
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Management Discussion & Analysis
- • Revenue and profitability details not disclosed in provided text
- • No segment or product line performance data available
Risk Factors
- • Newly added risk: Sept 2025 U.S. Commerce Dept national security probe on medical imports under Section 232, potential additional tariffs on key products
- • Most materially updated risk: July 31, 2025 tariff increase from 10% to 15% on imports from Costa Rica impacting supply chain costs
Annual Reports Archive10-K
AI-powered analysis of ICU MEDICAL INC/DE (ICUI) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of ICU MEDICAL INC/DE (ICUI) 10-Q quarterly reports filed with SEC EDGAR.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $2.3B | $2.3B | $2.4B | $2.2B |
| Gross Profit | $697.8M | $739.9M | $824.8M | $822.0M |
| Operating Income | — | $22.8M | $43.0M | $42.8M |
| Net Income | — | -$29.7M | -$117.7M | $732K |
| Gross Margin | 30.6% | 32.8% | 34.6% | 36.8% |
| Op. Margin | — | 1.0% | 1.8% | 1.9% |
| Net Margin | — | -1.3% | -4.9% | 0.0% |
| Balance Sheet | ||||
| Total Assets | — | $4.4B | $4.2B | $4.1B |
| Equity | — | $2.1B | $2.0B | $2.1B |
| ROE | — | -1.4% | -6.0% | 0.0% |
Source: XBRL financial data from ICU MEDICAL INC/DE (ICUI) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Feb 20, 2026 | — | — | |
8-K | Feb 19, 2026 | — | — | |
10-K | Feb 19, 2026 | Dec 31, 2025 | Analysis | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | — | |
10-K | Feb 27, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 7, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Feb 27, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 6, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 7, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Feb 27, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 7, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 9, 2022 | Jun 30, 2022 | — | |
10-Q | May 9, 2022 | Mar 31, 2022 | — | |
10-K | Feb 25, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 5, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 4, 2021 | Jun 30, 2021 | — | |
10-Q | May 7, 2021 | Mar 31, 2021 | — | |
10-K | Feb 26, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 6, 2020 | Sep 30, 2020 | — | |
10-Q | Aug 10, 2020 | Jun 30, 2020 | — | |
10-Q | May 8, 2020 | Mar 31, 2020 | — |
Frequently Asked Questions
What are the latest ICUI SEC filings in 2026?
ICU MEDICAL INC/DE (ICUI) has filed a 10-K annual report on February 19, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on February 20, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ICUI file its most recent 10-K annual report?
ICU MEDICAL INC/DE (ICUI) filed its most recent 10-K annual report on February 19, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ICUI 10-Q quarterly reports?
ICU MEDICAL INC/DE (ICUI)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every ICUI 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ICUI filed recently?
ICU MEDICAL INC/DE (ICUI)'s most recent 8-K was filed on February 20, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ICUI insider trading activity (Form 4)?
SignalX aggregates every ICUI Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ICUI file with the SEC?
ICU MEDICAL INC/DE (ICUI) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ICUI filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for ICU MEDICAL INC/DE (ICUI).
What is ICUI's SEC CIK number?
ICU MEDICAL INC/DE (ICUI)'s SEC CIK (Central Index Key) number is 883984. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 883984 to look up all ICUI filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ICUI return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from ICU MEDICAL INC/DE (ICUI) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of ICU MEDICAL INC/DE SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 54+ filings.